ArticleTherapeutic advances in neurological disorders2021

Teriflunomide in relapsing-remitting multiple sclerosis: outcomes by age and pre-treatment status.

Boris A Kallmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.